Cibc Asset Management Inc Pfizer Inc Transaction History

Cibc Asset Management Inc

$25.9 Billion
Q2 2024

A detailed history of Cibc Asset Management Inc transactions in Pfizer Inc stock. As of the latest transaction made, Cibc Asset Management Inc holds 1,003,350 shares of PFE stock, worth $29.8 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

1,003,350

Previous 1,895,998 47.08%

Holding current value

$29.8 Million

Previous $52.6 Million 46.64%

% of portfolio

0.11%

Previous 0.2%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$25.26 - $29.6 $22.5 Million - $26.4 Million	-892,648 Reduced 47.08%	1,003,350 $28.1 Million
Q1 2024 May 09, 2024	BUY	$25.89 - $29.73 $102,058 - $117,195	3,942 Added 0.21%	1,895,998 $52.6 Million
Q4 2023 Feb 13, 2024	SELL	$26.13 - $33.94 $3.07 Million - $3.99 Million	-117,448 Reduced 5.84%	1,892,056 $54.5 Million
Q3 2023 Oct 30, 2023	BUY	$32.09 - $37.51 $1.28 Million - $1.5 Million	39,946 Added 2.03%	2,009,504 $66.7 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $7.78 Million - $9 Million	215,373 Added 12.28%	1,969,558 $72.2 Million
Q1 2023 May 12, 2023	BUY	$39.39 - $51.28 $5.08 Million - $6.62 Million	128,999 Added 7.94%	1,754,185 $71.6 Million
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $1.8 Million - $2.35 Million	43,150 Added 2.73%	1,625,186 $83.3 Million
Q3 2022 Nov 03, 2022	BUY	$43.76 - $53.42 $36.6 Million - $44.7 Million	836,997 Added 112.34%	1,582,036 $69.2 Million
Q2 2022 Aug 09, 2022	BUY	$46.53 - $55.17 $1.62 Million - $1.92 Million	34,734 Added 4.89%	745,039 $39.1 Million
Q1 2022 May 06, 2022	BUY	$45.75 - $56.69 $2.58 Million - $3.2 Million	56,462 Added 8.64%	710,305 $36.8 Million
Q4 2021 Feb 08, 2022	SELL	$41.32 - $61.25 $7.7 Million - $11.4 Million	-186,468 Reduced 22.19%	653,843 $38.6 Million
Q3 2021 Nov 09, 2021	SELL	$39.25 - $50.42 $4.7 Million - $6.04 Million	-119,747 Reduced 12.47%	840,311 $36.1 Million
Q2 2021 Aug 16, 2021	SELL	$35.91 - $40.68 $88,123 - $99,828	-2,454 Reduced 0.25%	960,058 $37.6 Million
Q1 2021 May 14, 2021	BUY	$33.49 - $37.77 $1.39 Million - $1.56 Million	41,359 Added 4.49%	962,512 $34.9 Million
Q4 2020 Feb 03, 2021	SELL	$33.47 - $42.56 $1.43 Million - $1.82 Million	-42,855 Reduced 4.45%	921,153 $33.9 Million
Q3 2020 Nov 05, 2020	BUY	$31.75 - $37.25 $867,949 - $1.02 Million	27,337 Added 2.92%	964,008 $35.4 Million
Q2 2020 Jul 28, 2020	BUY	$30.12 - $36.54 $6.87 Million - $8.33 Million	227,943 Added 32.16%	936,671 $30.6 Million
Q1 2020 Apr 30, 2020	SELL	$27.03 - $38.62 $431,993 - $617,224	-15,982 Reduced 2.21%	708,728 $23.1 Million
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $1.45 Million - $1.64 Million	43,933 Added 6.45%	724,710 $28.4 Million
Q3 2019 Oct 30, 2019	BUY	$32.49 - $42.13 $3.32 Million - $4.31 Million	102,277 Added 17.68%	680,777 $24.5 Million
Q2 2019 Aug 05, 2019	BUY	$36.98 - $41.52 $612,203 - $687,363	16,555 Added 2.95%	578,500 $25.1 Million
Q1 2019 May 06, 2019	BUY	$37.5 - $41.2 $268,762 - $295,280	7,167 Added 1.29%	561,945 $23.9 Million
Q4 2018 Feb 12, 2019	SELL	$38.47 - $43.86 $2.42 Million - $2.76 Million	-63,016 Reduced 10.2%	554,778 $24.2 Million
Q3 2018 Nov 02, 2018	BUY	$34.47 - $41.81 $166,214 - $201,607	4,822 Added 0.79%	617,794 $27.2 Million
Q2 2018 Aug 09, 2018	BUY	$32.98 - $35.16 $1.27 Million - $1.35 Million	38,416 Added 6.69%	612,972 $22.2 Million
Q1 2018 Apr 30, 2018	SELL	$31.91 - $37.02 $899,766 - $1.04 Million	-28,197 Reduced 4.68%	574,556 $20.4 Million
Q4 2017 Feb 02, 2018	SELL	$33.26 - $35.29 $12.4 Million - $13.2 Million	-373,619 Reduced 38.27%	602,753 $21.8 Million
Q3 2017 Nov 06, 2017	BUY	$31.0 - $34.15 $30.3 Million - $33.3 Million	976,372	976,372 $34.9 Million

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $167B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.

Account

Cibc Asset Management Inc Pfizer Inc Transaction History